Tina Singh
GlaxoSmithKline (Belgium)(BE)
Publications by Year
Research Areas
Viral gastroenteritis research and epidemiology, Tuberculosis Research and Epidemiology, Liver Disease and Transplantation, Liver Disease Diagnosis and Treatment, Vaccine Coverage and Hesitancy
Most-Cited Works
- → Phase 2b Controlled Trial of M72/AS01 E Vaccine to Prevent Tuberculosis(2018)397 cited
- → Combined measles-mumps-rubella-varicella vaccine and febrile convulsions: the risk considered in the broad context(2023)15 cited
- Heptral (ademetionine) in patients with intrahepatic cholestasis in chronic liver disease due to non-alcoholic liver disease: results of a multicentre observational study in India.(2013)
- → Review of Over 15 Years Postmarketing Safety Surveillance Spontaneous Data for the Human Rotavirus Vaccine (Rotarix) on Intussusception(2022)9 cited
- → Direct and early detection of <I>Mycobacterium tuberculosis</I> complex and rifampicin resistance from sputum smears(2013)8 cited
- → Safety and reactogenicity of a liquid formulation of human rotavirus vaccine (porcine circovirus-free): A phase III, observer-blind, randomized, multi-country study(2022)6 cited
- → Heptral® (Ademetionine) in Intrahepatic Cholestasis due to Chronic Non-Alcoholic Liver Disease: Subgroup Analysis of Results of a Multicentre Observational Study in India(2014)5 cited
- → Clinical trials show similar safety outcomes including febrile convulsion rates for GSK’s and Merck’s measles-mumps-rubella (MMR) vaccines(2023)5 cited
- → Heptral® (Ademetionine) in Patients with Intrahepatic Cholestasis due to Chronic Alcoholic Liver Disease: Results of a Multicentre Observational Study in Indian Patients(2014)3 cited
- → Concomitant administration of a liquid formulation of human rotavirus vaccine (porcine circovirus-free) with routine childhood vaccines in infants in the United States: Results from a phase 3, randomized trial(2020)3 cited